2025-07-19 - Analysis Report
Okay, here's a report summarizing the provided data for Albemarle Corp (ALB), including numerical data, analysis, and key takeaways.

## Albemarle Corp (ALB) Stock Analysis

**Company Overview:** Albemarle Corp is a specialty chemicals company with leading positions in lithium, bromine specialties, and catalysts.

### 1. Performance vs. S&P 500 (VOO)

*   **ALB Cumulative Return:** 28.10%
*   **VOO Cumulative Return:** 96.72%
*   **Absolute Divergence:** -78.7
*   **Relative Divergence:** 2.9

**Analysis:** ALB has significantly underperformed the S&P 500 (VOO) over the analyzed period. The relative divergence of 2.9 indicates that ALB's underperformance is near the lower end of its historical range compared to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2015-2017  | 99.0%  | 8.1%  | 70.0%  | 0.0  | 15.1   |
| 2016-2018  | 13.0%  | 58.0% | -5.0%  | 0.0  | 9.1    |
| 2017-2019  | -44.0% | 58.0% | -74.0% | -0.0 | 8.6    |
| 2018-2020  | 101.0% | 62.9% | 81.0%  | 0.6  | 17.4   |
| 2019-2021  | 268.0% | 62.9% | 220.0% | 0.6  | 27.5   |
| 2020-2022  | 239.0% | 75.6% | 237.0% | 0.8  | 25.5   |
| 2021-2023  | -53.0% | 77.5% | -71.0% | 0.6  | 17.0   |
| 2022-2024  | -200.0%| 77.5% | -225.0%| 0.7  | 10.1   |
| 2023-2025  | -320.0%| 77.5% | -369.0%| 3.0  | 9.1    |

**Analysis:**

*   **CAGR & MDD:** The CAGR (Compound Annual Growth Rate) shows significant volatility, ranging from high positive values (e.g., 268.0% in 2019-2021) to substantial negative values recently (-320% in 2023-2025).  MDD (Maximum Drawdown) is consistently high, indicating significant risk.
*   **Alpha:** Alpha values are generally positive during periods of high growth but are strongly negative in recent years, reflecting underperformance relative to the market.
*   **Beta:** Beta values are relatively low, suggesting that ALB's price is not strongly correlated with the broader market (S&P 500). A recent high Beta value of 3.0 from 2023-2025 suggests that the stock has become very volatile to the market.
*   **Cap(B):** Market Capitalization has fluctuated over time, reflecting changing investor sentiment and market conditions.

### 2. Recent Stock Price Movement

*   **Current Price:** \$77.07
*   **Previous Close:** \$75.74
*   **Change:** \$1.76
*   **5-day Moving Average:** 73.02
*   **20-day Moving Average:** 67.08
*   **60-day Moving Average:** 61.78

**Analysis:** The stock price is above its 5, 20, and 60-day moving averages, suggesting a short-term upward trend. The recent price increase of \$1.76 indicates a positive momentum.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3399 (Low Risk)
*   **RSI:** 68.97 (Approaching overbought territory)
*   **PPO:** 1.05
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Divergence Change:** -0.2 (Short-term decline)
*   **Expected Return:** 4092.4% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI indicates a low-risk environment, which is somewhat contradictory given the stock's recent underperformance and high MDD.
*   The RSI is approaching overbought levels, suggesting the recent upward movement may be unsustainable in the short term.
*   The PPO indicates that the short-term moving average is above the long-term moving average, reinforcing the recent upward trend.
*   The Hybrid Signal suggests a cautious approach, recommending buying a portion of available cash, likely driven by the low MRI but tempered by other factors.
*   The negative change in relative divergence indicates weakening performance compared to the S&P 500.
*   The high expected return suggests significant potential upside over the long term, assuming a buy-and-hold strategy. The price change of $1.76 indicates a recent positive trend, which could be a short-term reaction to news or market sentiment.

### 4. Recent News & Significant Events

*   **2025-07-16:** Major business developments, regulatory changes, or market events impacting Albemarle Corp.
*   **2025-07-19:** Analyst discussions on recent performance and outlook, considering industry trends and global economic factors.
*   **2025-07-18:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-15:** Market experts highlighting risks and opportunities, advising investors to monitor news and company announcements.

**Analysis:** Recent news suggests ALB is experiencing volatility and is subject to significant market and industry scrutiny. Investors should closely monitor news and analyst opinions for potential risks and opportunities.

### 5. Recent Earnings Analysis

| 날짜       | EPS    | 매출       |
|------------|--------|------------|
| 2025-04-30 | 0      | 1.08 B\$   |
| 2024-11-06 | -9.45  | 1.35 B\$   |
| 2024-07-31 | -1.96  | 1.43 B\$   |
| 2024-05-01 | -0.08  | 1.36 B\$   |
| 2025-04-30 | -0.08  | 1.36 B\$   |

**Analysis:** The company has experienced declining revenues over the recent quarters. The EPS (Earnings Per Share) has been negative in most recent periods, indicating profitability challenges.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|----------------|
| 2025-03-31 | \$1.08B    | 14.51%         |
| 2024-12-31 | \$1.23B    | 11.22%         |
| 2024-09-30 | \$1.35B    | -7.68%         |
| 2024-06-30 | \$1.43B    | -0.74%         |
| 2024-03-31 | \$1.36B    | 2.86%          |

**Capital and Profitability:**

| Quarter    | Equity     | ROE       |
|------------|------------|-----------|
| 2025-03-31 | \$10.03B   | 0.41%     |
| 2024-12-31 | \$9.96B    | 0.76%     |
| 2024-09-30 | \$10.24B   | -10.44%    |
| 2024-06-30 | \$11.22B   | -1.68%     |
| 2024-03-31 | \$11.53B   | 0.02%     |

**Analysis:** The financial data indicates declining revenue and inconsistent profitability. The negative profit margins in some quarters are concerning. ROE (Return on Equity) has been low or negative, indicating inefficient use of equity.

### 7. Overall Analysis and Conclusion

Albemarle Corp (ALB) has significantly underperformed the S&P 500 recently. While the MRI suggests low market risk, the high MDD and negative Alpha values indicate that ALB is a risky investment. Recent earnings have been weak, with declining revenue and negative EPS. The stock has shown a recent positive price movement, but the RSI is approaching overbought levels. The long-term expected return is high, but investors should be aware of the significant risks involved. Recent news points to volatility and scrutiny.
